Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: J Clin Psychopharmacol. 2015 Feb;35(1):34–42. doi: 10.1097/JCP.0000000000000246

Figure 2.

Figure 2

Mean weekly values for percent days drinking for subjects in the levetiracetam (LEV), placebo (PLC), topiramate (TOP), and zonisamide (ZON) groups. These values are presented for the percent days drinking obtained during the prescreening (week 0), titration (weeks 1-7), and maintenance phases of the study (weeks 8-12).